{"schema_version":"secwatch.filing_event.v1","accession":"0000898432-23-000021","form_type":"8-K","ticker":"IRMD","cik":"0001325618","company_name":"IRADIMED CORP","filed_at":"2023-01-19T23:59:59+00:00","discovered_at":"2026-05-14T18:03:44.394803+00:00","generated_at":"2026-06-20T12:57:33.294008+00:00","sec_items":["2.02","9.01"],"event_type":"earnings","sentiment":"positive","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"iRadimed reports preliminary Q4 revenue $14.9M (+25% YoY); issues FY2023 guidance $61M-$63M","bullets":["Q4 2022 preliminary revenue $14.9M, up 25% YoY, above guidance of $14.1M-$14.8M.","Sixth consecutive quarterly revenue record; orders exceeded shipments, increasing backlog.","FY2023 guidance: revenue $61M-$63M, GAAP EPS $1.10-$1.20, non-GAAP EPS $1.23-$1.34.","Q1 2023 guidance: revenue $14.6M-$14.9M, GAAP EPS $0.23-$0.25, non-GAAP EPS $0.26-$0.28.","Full year 2022 revenue grew 27.5% over 2021."],"urls":{"canonical":"https://secwatch.observer/filing/0000898432-23-000021","json":"https://secwatch.observer/filing/0000898432-23-000021.json","markdown":"https://secwatch.observer/filing/0000898432-23-000021.md","text":"https://secwatch.observer/filing/0000898432-23-000021.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/0000898432-23-000021-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/form8-k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-20T12:57:33.294008+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"469087f2c9c7d76cde9cfc02cb3da87cd04c50d0","claim":"IRADIMED CORP reported the full year 2023 results: revenue $61 million to $63 million, EPS GAAP diluted earnings per share of $1.10 to $1.20, and non-GAAP diluted earnings per share of $1.23 to $1.34. Guidance initiated.","evidence_excerpt":"For the full year 2023, the Company expects to report revenue of $61 million to $63 million, GAAP diluted earnings per share of $1.10 to $1.20, and non-GAAP diluted earnings per share of $1.23 to $1.34.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/0000898432-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the full year 2023"},{"label":"Revenue","value":"$61 million to $63 million"},{"label":"EPS","value":"GAAP diluted earnings per share of $1.10 to $1.20, and non-GAAP diluted earnings per share of $1.23 to $1.34"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"},{"claim_id":"d048759299da770fdea4e56f8db40c461e038a3d","claim":"IRADIMED CORP reported the fourth quarter ended December 31, 2022 results: revenue $14.9 million.","evidence_excerpt":"Fourth-quarter revenue is expected to be approximately $14.9 million","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/0000898432-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the fourth quarter ended December 31, 2022"},{"label":"Revenue","value":"$14.9 million"},{"label":"Result","value":"preliminary results"}],"fact_type":"earnings_release"},{"claim_id":"f7b4b5437176afed0729bd92f16a75dcc949acfc","claim":"IRADIMED CORP reported the first quarter of 2023 results: revenue $14.6 million to $14.9 million, EPS GAAP diluted earnings per share of $0.23 to $0.25, and non-GAAP diluted earnings per share of $0.26 to $0.28. Guidance initiated.","evidence_excerpt":"For the first quarter of 2023, the Company expects to report revenue of $14.6 million to $14.9 million, GAAP diluted earnings per share of $0.23 to $0.25, and non-GAAP diluted earnings per share of $0.26 to $0.28.","evidence_source":"SEC 8-K Item 2.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1325618/000089843223000021/0000898432-23-000021-index.htm","confidence":0.9,"family_label":"Earnings Releases","details":[{"label":"Period","value":"the first quarter of 2023"},{"label":"Revenue","value":"$14.6 million to $14.9 million"},{"label":"EPS","value":"GAAP diluted earnings per share of $0.23 to $0.25, and non-GAAP diluted earnings per share of $0.26 to $0.28"},{"label":"Guidance","value":"initiated"},{"label":"Result","value":"guidance update"}],"fact_type":"earnings_release"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}